3 Charts About Medicare Drug Price Negotiations
A look at key elements of the process, what it means for beneficiaries, and the public's views View in browser 3 Charts About Medicare Drug Price Negotiations Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure drugs covered under Medicare Part D (starting in 2026) and Part B (starting in 2028). Part D covers retail prescription drugs and Part B covers physician-administered medications. This new requirement is the culmination of years of